[go: up one dir, main page]

 
 
Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Article Types

Countries / Regions

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Search Results (479)

Search Parameters:
Keywords = diarrhoea

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
11 pages, 2321 KiB  
Case Report
Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infections in a Cystic Fibrosis Child Previously Screen Positive, Inconclusive Diagnosis (CFSPID): A Case Report
by Riccardo Marsiglia, Stefania Pane, Federica Del Chierico, Alessandra Russo, Pamela Vernocchi, Lorenza Romani, Sabrina Cardile, Antonella Diamanti, Luisa Galli, Agnese Tamborino, Vito Terlizzi, Paola De Angelis, Giulia Angelino and Lorenza Putignani
Microorganisms 2024, 12(10), 2059; https://doi.org/10.3390/microorganisms12102059 - 12 Oct 2024
Viewed by 473
Abstract
Clostridioides difficile infection (CDI) is generally treated with vancomycin, metronidazole or fidaxomicin, although fecal microbiota transplantation (FMT) represents a promising therapeutic option for antibiotic-resistant recurrent C. difficile infections (rCDIs) in adults. In pediatric cystic fibrosis (CF) patients, CDIs are generally asymptomatic and respond [...] Read more.
Clostridioides difficile infection (CDI) is generally treated with vancomycin, metronidazole or fidaxomicin, although fecal microbiota transplantation (FMT) represents a promising therapeutic option for antibiotic-resistant recurrent C. difficile infections (rCDIs) in adults. In pediatric cystic fibrosis (CF) patients, CDIs are generally asymptomatic and respond to treatment. Here, we present the case of an 8-year-old female, initially diagnosed as “CFTR-related metabolic syndrome/cystic fibrosis screen positive, inconclusive diagnosis” (CMRS/CFSPID), who then progressed to CF at 12 months. In the absence of CF-related symptoms, she presented multiple and disabling episodes of bloody diarrhoea with positive tests for C. difficile antigen and A/B toxin. After conventional treatments failed and several CDI relapses, FMT was proposed. Donor screening and GM donor–receiver matching identified her mother as a donor. Metataxonomy and targeted metabolomics provided, through a pre- and post-FMT time course, gut microbiota (GM) profiling to assess GM engraftment. At first, the GM map revealed severe dysbiosis, with a prevalence of Bacteroidetes and Proteobacteria (i.e., Klebsiella spp., Escherichia coli), a reduction in Firmicutes, a GM nearly entirely composed of Enterococcaceae (i.e., Enterococcus) and an almost complete depletion of Verrucomicrobia and Actinobacteria, mostly represented by Veillonella dispar. Post FMT, an increment in Bifidobacterium spp. and Collinsella spp. with a decrease in V. dispar restored intestinal eubiosis. Consistently, four weeks after FMT treatment, the child’s gut symptoms cleared, without CDI recurrence. Full article
(This article belongs to the Special Issue State of the Art of Gut Microbiota in Italy (2023, 2024))
Show Figures

Figure 1

Figure 1
<p>Diagnostic map of the GM of the CFSPID patient compared to the GM profiles of a reference age-matched healthy subject group, exploited as a control (CTRL) group. The histogram refers to OTU distributions at the phylum (<b>A</b>) and family (<b>B</b>) levels.</p>
Full article ">Figure 2
<p>Diagnostic map of the GM of the CFSPID patient compared to the GM profiles of a reference age-matched healthy subject group, exploited as a control (CTRL). The histogram refers to OTU distributions at the genus (<b>A</b>) and species (<b>B</b>) levels.</p>
Full article ">Figure 3
<p>GM map of the CFSPID patient at the pre-FMT T<sub>−1</sub> time point compared to the GM map of the mother. The cake representations refer to the OTU distributions reported at the phylum level.</p>
Full article ">Figure 4
<p>Gut microbiota profiles represented at the phylum level (<b>A</b>) and fecal SCFAs levels (<b>B</b>) of the patient pre and post FMT at T<sub>0</sub>, T<sub>+1</sub>, T<sub>+5</sub>, T<sub>+15</sub> and T<sub>+31</sub> time points, reported as days.</p>
Full article ">
16 pages, 3771 KiB  
Article
A Longitudinal Study of Escherichia coli Clinical Isolates from the Tracheal Aspirates of a Paediatric Patient—Strain Type Similar to Pandemic ST131
by Brankica Filipic, Milan Kojic, Zorica Vasiljevic, Aleksandar Sovtic, Ivica Dimkic, Emily Wood and Alfonso Esposito
Microorganisms 2024, 12(10), 1990; https://doi.org/10.3390/microorganisms12101990 - 30 Sep 2024
Viewed by 540
Abstract
Escherichia coli is a Gram-negative bacterium and part of the intestinal microbiota. However, it can cause various diarrhoeal illnesses, i.e., traveller’s diarrhoea, dysentery, and extraintestinal infections when the bacteria are translocated from the intestine to other organs, such as urinary tract infections, abdominal [...] Read more.
Escherichia coli is a Gram-negative bacterium and part of the intestinal microbiota. However, it can cause various diarrhoeal illnesses, i.e., traveller’s diarrhoea, dysentery, and extraintestinal infections when the bacteria are translocated from the intestine to other organs, such as urinary tract infections, abdominal and pelvic infections, pneumonia, bacteraemia, and meningitis. It is also an important pathogen in intensive care units where cross-infection may cause intrahospital spread with serious consequences. Within this study, four E. coli isolates from the tracheal aspirates of a tracheotomised paediatric patient on chronic respiratory support were analysed and compared for antibiotic resistance and virulence potential. Genomes of all four isolates (5381a, 5381b, 5681, 5848) were sequenced using Oxford Nanopore Technology. According to PFGE analysis, the clones of isolates 5681 and 5848 were highly similar, and differ from 5381a and 5381b which were isolated first chronologically. All four E. coli isolates belonged to an unknown sequence type, related to the E. coli ST131, a pandemic clone that is evolving rapidly with increasing levels of antimicrobial resistance. All four E. coli isolates in this study exhibited a multidrug-resistant phenotype as, according to MIC data, they were resistant to ceftriaxone, ciprofloxacin, doxycycline, minocycline, and tetracycline. In addition, principal component analyses revealed that isolates 5681 and 5848, which were recovered later than 5381a and 5381b (two weeks and three weeks, respectively) possessed more complex antibiotic resistance genes and virulence profiles, which is concerning considering the short time period during which the strains were isolated. Full article
(This article belongs to the Special Issue Overviews of Clinical Microbial Infection)
Show Figures

Figure 1

Figure 1
<p>Sample collection and longitudinal bacterial isolation from the hospitalised patient. The first two isolates were not available for this study. TA—Tracheal aspirate. Figure made with <a href="http://Biorender.com" target="_blank">Biorender.com</a>, accessed on 27 February 2024.</p>
Full article ">Figure 2
<p>DNA patterns of <span class="html-italic">E. coli</span> isolates obtained by PFGE (<span class="html-italic">Xba</span>I macrorestriction fingerprint). λ-ladder (λ-concatemers; New England Biolabs), 1—strain 5381a; 2—strain 5381b; 3—strain 5681; 4—strain 5848. The differences between the strains are indicated by the arrows.</p>
Full article ">Figure 3
<p>Visualisation of the pan-genome constructed using Roary based on the core and accessory genes showing phylogenetic relatedness of the isolates by blue (present) and white (absent) fragments.</p>
Full article ">Figure 4
<p>Single nucleotide polymorphisms (SNPs) occurring in clinically relevant genes: (<b>a</b>) the number of exclusive and shared mutated genes among the four strains; (<b>b</b>) the number of mutations within each gene, represented as a heatmap.</p>
Full article ">Figure 5
<p>The individual factor map (<b>a</b>) and variables factor map (<b>b</b>) of PCA on different genetic determinants of antibiotic resistance, detected in genomes by the ResFinder database.</p>
Full article ">Figure 6
<p>The individual factor map (<b>a</b>) and variables factor map (<b>b</b>) of PCA on different virulence factors, detected in genomes by VFDB.</p>
Full article ">
15 pages, 324 KiB  
Review
Antimicrobial Resistance in Diverse Escherichia coli Pathotypes from Nigeria
by Kenneth Nnamdi Anueyiagu, Chibuzor Gerald Agu, Uzal Umar and Bruno Silvester Lopes
Antibiotics 2024, 13(10), 922; https://doi.org/10.3390/antibiotics13100922 - 26 Sep 2024
Viewed by 737
Abstract
Escherichia coli is a gram-negative commensal bacterium living in human and animal intestines. Its pathogenic strains lead to high morbidity and mortality, which can adversely affect people by causing urinary tract infections, food poisoning, septic shock, or meningitis. Humans can contract E. coli [...] Read more.
Escherichia coli is a gram-negative commensal bacterium living in human and animal intestines. Its pathogenic strains lead to high morbidity and mortality, which can adversely affect people by causing urinary tract infections, food poisoning, septic shock, or meningitis. Humans can contract E. coli by eating contaminated food—such as raw or undercooked raw milk, meat products, and fresh produce sold in open markets—as well as by coming into contact with contaminated settings like wastewater, municipal water, soil, and faeces. Some pathogenic strains identified in Nigeria, include Enterohemorrhagic (Verotoxigenic), Enterotoxigenic, Enteropathogenic, Enteroinvasive, and Enteroaggregative E. coli. This causes acute watery or bloody diarrhoea, stomach cramps, and vomiting. Apart from the virulence profile of E. coli, antibiotic resistance mechanisms such as the presence of blaCTX-M found in humans, animals, and environmental isolates are of great importance and require surveillance and monitoring for emerging threats in resource-limited countries. This review is aimed at understanding the underlying mechanisms of evolution and antibiotic resistance in E. coli in Nigeria and highlights the use of improving One Health approaches to combat the problem of emerging infectious diseases. Full article
20 pages, 524 KiB  
Review
Microscopic Colitis: An Underestimated Disease of Growing Importance
by Kamil Rutkowski, Karina Udrycka, Barbara Włodarczyk and Ewa Małecka-Wojciesko
J. Clin. Med. 2024, 13(19), 5683; https://doi.org/10.3390/jcm13195683 - 24 Sep 2024
Viewed by 455
Abstract
The aim of this paper is to raise awareness of MC as a clinically significant condition and to highlight its under-recognition, risk factors, diagnosis, management, and complications. This paper underlines the diagnostic and therapeutic challenges associated with the often nonspecific symptoms of MC. [...] Read more.
The aim of this paper is to raise awareness of MC as a clinically significant condition and to highlight its under-recognition, risk factors, diagnosis, management, and complications. This paper underlines the diagnostic and therapeutic challenges associated with the often nonspecific symptoms of MC. In order to create this article, we reviewed available articles found in the PubMed database and searched for articles using the Google Scholar platform. Microscopic colitis (MC) is a chronic inflammatory bowel disease, classified into three types: lymphocytic, collagenous, and unspecified. The average age of onset of MC is around 62–65 years and the disease is more common in women than men (nine times more common). The main symptom of MC is watery diarrhoea without blood, other symptoms include defecatory urgency, faecal incontinence, abdominal pain, nocturnal bowel movements, and weight loss. Once considered a rare disease, MC is now being diagnosed with increasing frequency, but diagnosis remains difficult. To date, a number of causative factors for MC have been identified, including smoking, alcohol consumption, medications (including NSAIDs, PPIs, SSRIs, and ICPIs), genetic factors, autoimmune diseases, bile acid malabsorption, obesity, appendicitis, and intestinal dysbiosis. It may be difficult to recognize and should be differentiated from inflammatory bowel diseases (Crohn’s disease and ulcerative colitis), irritable bowel syndrome (IBS), coeliac disease, infectious bowel disease, and others. Diagnosis involves biopsy at colonoscopy and histopathological evaluation of the samples. Treatment consists of budesonide oral (the gold standard) or enema. Alternatives include bile acid sequestrants (cholestyramine, colesevelam, and colestipol), biologics (infliximab, adalimumab, and vedolizumab), thiopurines, methotrexate, and rarely, surgery. Full article
(This article belongs to the Section Gastroenterology & Hepatopancreatobiliary Medicine)
Show Figures

Figure 1

Figure 1
<p>The criteria for diarrhoea remission and activity according to Hjörtswang [<a href="#B93-jcm-13-05683" class="html-bibr">93</a>].</p>
Full article ">
16 pages, 7214 KiB  
Article
Molecular Confirmation, Epidemiology, and Pathophysiology of Ehrlichia canis Prevalence in Eastern India
by Ankita Chakraborty, Prasana Kumar Rath, Susen Kumar Panda, Bidyut Prava Mishra, Manaswini Dehuri, Sangram Biswal, Manoj Kumar Jena, Basanta Pravas Sahu, Biswaranjan Paital and Dipak Kumar Sahoo
Pathogens 2024, 13(9), 803; https://doi.org/10.3390/pathogens13090803 - 16 Sep 2024
Viewed by 1146
Abstract
The present study aimed to investigate pathological epidemiology and molecular confirmation of Ehrlichia canis among pet dogs in Bhubaneswar, Odisha, a state in eastern India. A total of 178 dogs were screened for Ehrlichiosis based on history, clinical signs, blood, and buffy coat [...] Read more.
The present study aimed to investigate pathological epidemiology and molecular confirmation of Ehrlichia canis among pet dogs in Bhubaneswar, Odisha, a state in eastern India. A total of 178 dogs were screened for Ehrlichiosis based on history, clinical signs, blood, and buffy coat smear examination, resulting in only 56 dogs (31.46%) screening positive. The epidemiological study recorded a non-significant (p ≥ 0.05) increase in incidences among male dogs (68%), German Shepherds (25%), dogs more than 20 kg body weight (75%), in the summer months (55%), and dogs housed in pukka houses with exposure to the outside (59%). The majority of the infected dogs had a history of tick infestation (79%) at some point in their lives. Clinical signs showed non-typical manifestations like fever, lethargy, diarrhoea, epistaxis, hind limb edema, and corneal opacity. Haematological studies revealed anaemia and thrombocytopenia along with neutrophilia with relative lymphopenia and monocytosis. A decreasing trend was observed in the levels of total protein and albumin, with an increase in the levels of globulin, alanine aminotransferase, alanine aminotransferase, aspartate aminotransferase, blood urea nitrogen, and creatinine. The ultrasonography studies revealed hepatosplenomegaly along with hyper-echogenicity in various organs. Proteinuria and haematuria were consistent, along with the presence of bile salts in the urine of affected dogs. Molecular confirmation from n-type PCR data using Ehrlichia-specific primers targeting the p28 gene (843 bp) was done, and the identified gene sequences submitted to NCBI databases have accession numbers OQ383671-OQ383674 and OP886674-OP886677. Ticks collected from dogs were identified morphologically through microscopy and scanning electron microscopy as Rhipicephalus sanguineus. Full article
(This article belongs to the Special Issue Molecular Epidemiology of Pathogenic Agents)
Show Figures

Figure 1

Figure 1
<p>Occurrence of <span class="html-italic">Ehrlichia canis</span> in blood cells of buffy coat smear dogs in eastern India. (<b>A</b>) Presence of morula of <span class="html-italic">Ehrlichia canis</span> in neutrophils in blood smear, (<b>B</b>) Presence of morula of <span class="html-italic">Ehrlichia canis</span> in monocytes in buffy coat smear. The pictures taken with 100× magnification.</p>
Full article ">Figure 2
<p>Clinical symptoms of Ehrlichiosis in eastern Indian dogs. (<b>A</b>) Epistaxis/Nasal bleeding in affected dogs, (<b>B</b>) Corneal opacity in Ehrlichiosis-affected dogs, (<b>C</b>) Oedema in affected dogs, (<b>D</b>) Presence of ticks on the hair coat of affected dogs.</p>
Full article ">Figure 3
<p>Pathophysiological manifestation in dogs under Ehrlichiosis in eastern India. (<b>A</b>) Congested oral mucosae in Ehrlichiosis-affected dogs, (<b>B</b>) Hind limb oedema in Ehrlichiosis-affected dogs, (<b>C</b>) Enlarged and icteric liver in Ehrlichiosis-affected dogs, (<b>D</b>) Haemorrhagic urinary bladder mucosae in Ehrlichiosis affected dogs.</p>
Full article ">Figure 4
<p>Histological studies in dogs under Ehrlichiosis. (<b>A</b>) Photomicrograph showing vacuolar degenerations, fatty changes, necrosis of hepatocytes around the central vein, (<b>B</b>) Photomicrograph showing necrosis of renal tubular epithelial cells with desquamation and presence of proteinaceous materials in renal tubules (H&amp;E-40×), (<b>C</b>) Photomicrograph showing alveolar degeneration and necrosis along with interstitial congestion and oedema of interstitial spaces (H&amp;E-40×), (<b>D</b>) Photomicrograph showing diffuse haemosiderosis in the spleen (H&amp;E-10×).</p>
Full article ">Figure 5
<p><span class="html-italic">Rhipicephalus sanguineus</span> in dog population under Ehrlichiosis. (<b>A</b>) Hexagonal basis capitulum and festoons of <span class="html-italic">R. sanguineus</span> magnification at 10×, (<b>B</b>) The enlarged anal plates, anal groove, and anus of <span class="html-italic">R. sanguineus</span> magnification at 100×.</p>
Full article ">Figure 6
<p>PCR product showing the bands through agarose gel electrophoresis at 843 bp.</p>
Full article ">Figure 7
<p>The phylogenetic tree was constructed by using the neighbour-joining (NJ) method with kimura 2- parameters based on nucleotide sequences of the p28 gene of <span class="html-italic">E. canis.</span> The black triangle indicates the isolates from the present investigation, whereas <span class="html-italic">E. chaffeensis</span> refers to an out-group. The numbers in the node indicate the similarly of the sequences between the compared respective two species.</p>
Full article ">Figure 8
<p>Comparative analysis of various diagnostic methods.</p>
Full article ">
16 pages, 817 KiB  
Article
Association of High Levels of Bullying and Cyberbullying with Test Anxiety in Boys and Girls Aged 10 to 16 Years
by Alba Rusillo-Magdaleno, Manuel J. De la Torre-Cruz, Alberto Ruiz-Ariza and Sara Suárez-Manzano
Educ. Sci. 2024, 14(9), 999; https://doi.org/10.3390/educsci14090999 - 11 Sep 2024
Viewed by 663
Abstract
The increase in cases of bullying and cyberbullying has raised concerns about its impact on the mental health of young people, particularly its relationship with test anxiety, underscoring the need to delve deeper into this issue. Therefore, the aim of this study was [...] Read more.
The increase in cases of bullying and cyberbullying has raised concerns about its impact on the mental health of young people, particularly its relationship with test anxiety, underscoring the need to delve deeper into this issue. Therefore, the aim of this study was to examine whether suffering and perpetrating aggressive acts (bullying and cyberbullying) are related to different dimensions of test anxiety. A total of 912 Spanish students (girls 52.7%) aged between 10 and 16 years (13.43 ± 1.73) participated in this study. The European Bullying Intervention Project Questionnaire, the European Cyberbullying Intervention Project Questionnaire, and the Test Anxiety Questionnaire (CAEX-A) were used. The association between test anxiety and bullying/cyberbullying (as victims and aggressors) was calculated via analysis of covariance (ANCOVA) and binary logistic regression. All analyses were performed separately for boys and girls and adjusted for age, body mass index, maternal educational level, and academic performance. Students in bullying or cyberbullying contexts achieved significantly higher values in practically all anxiety factors analyzed (p < 0.05), especially in cognitive responses: 33.14% and 22.56% for bullying and cyberbullying victims, respectively, and 22.56% and 23.9% for aggressors. Victims of cyberbullying harassment had a high risk (OR: 8.311) of suffering diarrhoea, palpitations, chest tightness, nausea and fainting during exams, as well as avoidance behaviors (OR: 5.106) (both p < 0.001). The results, disaggregated by gender, showed that the relationship between feeling bullied in face-to-face interactions and experiencing test anxiety was only evident for girls, which seems to place them in a more vulnerable situation. Female victimization, although less frequent, could have lasting and harmful consequences. These findings highlight the need not only to implement intervention strategies in the school setting aimed at preventing and reducing bullying and cyberbullying but also to address anxiety and its physical and cognitive manifestations in both victims and aggressors. Full article
Show Figures

Figure 1

Figure 1
<p>Means and error bars for all participants and differentiated by gender in the dimensions that compose test anxiety (physiological response, avoidance behavior and cognitive response). (<b>a</b>–<b>c</b>) distinguish between victims and non-victims of traditional bullying. (<b>d</b>–<b>f</b>) distinguish between victims and non-victims in cyberbullying.</p>
Full article ">Figure 2
<p>Means and error bars for all participants and differentiated by gender in the dimensions that compose test anxiety (physiological response, avoidance behavior and cognitive response). (<b>a</b>–<b>c</b>) distinguish between perpetrators and non-perpetrators of traditional bullying. (<b>d</b>–<b>f</b>) distinguish between perpetrators and non-perpetrators in cyberbullying.</p>
Full article ">Figure 2 Cont.
<p>Means and error bars for all participants and differentiated by gender in the dimensions that compose test anxiety (physiological response, avoidance behavior and cognitive response). (<b>a</b>–<b>c</b>) distinguish between perpetrators and non-perpetrators of traditional bullying. (<b>d</b>–<b>f</b>) distinguish between perpetrators and non-perpetrators in cyberbullying.</p>
Full article ">
5 pages, 429 KiB  
Case Report
Methaemoglobinaemia in an Infant with a Cow’s Milk Protein Allergy
by Wei Hao Lee
Emerg. Care Med. 2024, 1(3), 299-303; https://doi.org/10.3390/ecm1030030 - 11 Sep 2024
Viewed by 414
Abstract
Methaemoglobinaemia (MetHb) is a functional anaemia that can be life-threatening in severe cases. MetHb in adults and older children usually results from exposure to toxins from ingestion or skin exposure, whereas MetHb in infants under six months old usually occurs due to exposure [...] Read more.
Methaemoglobinaemia (MetHb) is a functional anaemia that can be life-threatening in severe cases. MetHb in adults and older children usually results from exposure to toxins from ingestion or skin exposure, whereas MetHb in infants under six months old usually occurs due to exposure to well water, severe metabolic acidosis from diarrhoea, or, in rare cases, secondary to cow’s milk protein allergy (CMPA). In this case report, a young infant presented acutely with shock secondary to profuse diarrhoea and MetHb requiring intravenous fluids and methylene blue and was subsequently diagnosed with CMPA. The early recognition and prompt treatment of CMPA may prevent the recurrence of MetHb symptoms and excessive diagnostic testing in this vulnerable population. Full article
Show Figures

Figure 1

Figure 1
<p>Baby Z’s weights before and after presentation and admissions.</p>
Full article ">
14 pages, 2141 KiB  
Article
Identification of Virulence Genes Associated with Pathogenicity of Translocating Escherichia coli with Special Reference to the Type 6 Secretion System
by Behnoush Asgari, Jarred R. Burke, Bonnie L. Quigley, Georgia Bradford, Eva Hatje, Anna Kuballa and Mohammad Katouli
Microorganisms 2024, 12(9), 1851; https://doi.org/10.3390/microorganisms12091851 - 6 Sep 2024
Viewed by 562
Abstract
Recent genomic characterisation of translocating Escherichia coli HMLN-1 isolated from mesenteric lymph nodes (MLNs) and blood of a patient with a fatal case of pancreatitis revealed the presence of a type 6 secretion system (T6SS) that was not present in non-translocating E. coli [...] Read more.
Recent genomic characterisation of translocating Escherichia coli HMLN-1 isolated from mesenteric lymph nodes (MLNs) and blood of a patient with a fatal case of pancreatitis revealed the presence of a type 6 secretion system (T6SS) that was not present in non-translocating E. coli strains. This strain was also genomically similar to adherent-invasive E. coli (AIEC) LF82 pathotype. We aimed to identify the role of T6SS-1 in the pathogenesis of this strain and other pathogenic E. coli. The HMLN-1 strain was initially tested for the presence of six virulence genes (VGs) associated with AIEC strains and an iron sequestering system. Additionally, HMLN-1’s interaction with a co-culture of Caco-2:HT29-MTX cells and its intra-macrophagic survival was evaluated. We subsequently screened a collection of 319 pathogenic E. coli strains isolated from patients with urinary tract infection (UTI), diarrhoea, inflammatory bowel disease (IBD) and septicaemia for the presence of T6SS-1 and its expression related to adhesion, invasion and translocation via the above co-culture of the intestinal cell lines. The results showed that HMLN-1 harboured four of the AIEC-associated VGs (dsbA, htrA, ompC and afaC). Screening of the pathogenic E. coli collection detected the presence of the T6SS-1 genes in septicaemic and UTI E. coli strains at a significantly higher level than diarrhoea and IBD strains (p < 0.0001). The high expression of T6SS-1 in E. coli HMLN-1 upon adhesion and invasion, as well as its high prevalence among extra-intestinal E. coli strains, suggests a role for T6SS-1 in the pathogenesis of translocating E. coli. Full article
(This article belongs to the Section Gut Microbiota)
Show Figures

Figure 1

Figure 1
<p>Cumulative number of translocating <span class="html-italic">E. coli</span> (mean ± SEM) of HMLN-1 and control strains over 120 min through a co-culture of Caco-2 and HT29-MTX cell lines. Strains tested were HMLN-1 <span class="html-fig-inline" id="microorganisms-12-01851-i001"><img alt="Microorganisms 12 01851 i001" src="/microorganisms/microorganisms-12-01851/article_deploy/html/images/microorganisms-12-01851-i001.png"/></span>, JM109 <span class="html-fig-inline" id="microorganisms-12-01851-i002"><img alt="Microorganisms 12 01851 i002" src="/microorganisms/microorganisms-12-01851/article_deploy/html/images/microorganisms-12-01851-i002.png"/></span>, 46-4 <span class="html-fig-inline" id="microorganisms-12-01851-i003"><img alt="Microorganisms 12 01851 i003" src="/microorganisms/microorganisms-12-01851/article_deploy/html/images/microorganisms-12-01851-i003.png"/></span>, 73–89 <span class="html-fig-inline" id="microorganisms-12-01851-i004"><img alt="Microorganisms 12 01851 i004" src="/microorganisms/microorganisms-12-01851/article_deploy/html/images/microorganisms-12-01851-i004.png"/></span> and KIC-1 <span class="html-fig-inline" id="microorganisms-12-01851-i005"><img alt="Microorganisms 12 01851 i005" src="/microorganisms/microorganisms-12-01851/article_deploy/html/images/microorganisms-12-01851-i005.png"/></span>. Only significant values are shown. * At two hours, <span class="html-italic">E. coli</span> HMLN-1 vs. KIC-1, JM109, 46-4 and 73–89 (<span class="html-italic">p</span> = 0.0243). All tests were conducted in triplicate, and the results were expresses as mean ± SEM.</p>
Full article ">Figure 2
<p>Quantitative PCR confirmed the upregulation of the T6SS genes <span class="html-italic">vgr</span>G (<b>a</b>) and <span class="html-italic">clp</span>V (<b>b</b>) upon interaction with the co-culture of Caco-2:HT29-MTX compared to the control. Pure culture of the <span class="html-italic">E. coli</span> strain HMLN-1 was used as a control. All tests were carried out in three biological replicates, and the results were expressed as mean ± SEM.</p>
Full article ">
14 pages, 4307 KiB  
Article
Detection of Gastrointestinal Pathogens with Zoonotic Potential in Horses Used in Free-Riding Activities during a Countrywide Study in Greece
by Panagiota Tyrnenopoulou, Katerina Tsilipounidaki, Zoi Florou, Christos-Georgios Gkountinoudis, Konstantina Tyropoli, Alexandros Starras, Christina Peleki, Danai Marneris, Nikoletta Arseniou, Daphne T. Lianou, Eleni I. Katsarou, Efthymia Petinaki and George C. Fthenakis
Animals 2024, 14(17), 2566; https://doi.org/10.3390/ani14172566 - 3 Sep 2024
Viewed by 514
Abstract
The objectives of this study were (a) to detect zoonotic gastrointestinal pathogens in faecal samples of horses using the FilmArray® GI Panel and (b) to identify variables potentially associated with their presence. Faecal samples collected from 224 horses obtained during a countrywide [...] Read more.
The objectives of this study were (a) to detect zoonotic gastrointestinal pathogens in faecal samples of horses using the FilmArray® GI Panel and (b) to identify variables potentially associated with their presence. Faecal samples collected from 224 horses obtained during a countrywide study in Greece were tested by means of the BioFire® FilmArray® Gastrointestinal (GI) Panel, which uses multiplex-PCR technology for the detection of 22 pathogens. Gastrointestinal pathogens were detected in the faecal samples obtained from 97 horses (43.3%). Zoonotic pathogens were detected more frequently in samples from horses in courtyard housing (56.0%) than in samples from horses in other housing types (39.7%) (p = 0.040). The most frequently detected zoonotic pathogens were enteropathogenic Escherichia coli (19.2% of horses) and Shiga-like toxin-producing E. coli stx1/stx2 (13.8%). During multivariable analysis, two variables emerged as significant predictors for the outcome ‘detection of at least one zoonotic pathogen in the faecal sample from an animal’: (a) the decreasing age of horses (p = 0.0001) and (b) the presence of livestock at the same premises as the horses (p = 0.013). As a significant predictor for the outcome ‘detection of two zoonotic pathogens concurrently in the faecal sample from an animal’, only the season of sampling of animals (autumn) emerged as significant in the multivariable analysis (p = 0.049). The results indicated a diversity of gastrointestinal pathogens with zoonotic potential in horses and provided evidence for predictors for the infections; also, they can serve to inform horse owners and handlers regarding the possible risk of transmission of pathogens with zoonotic potential. In addition, our findings highlight the importance of continuous surveillance for zoonotic pathogens in domestic animals. Full article
(This article belongs to the Section Equids)
Show Figures

Figure 1

Figure 1
<p>Location of horses (<span class="html-italic">n</span> = 224) from which faecal samples were collected in Greece.</p>
Full article ">Figure 2
<p>Proportion of faecal samples from horses (<span class="html-italic">n</span> = 224) in Greece, in which zoonotic gastrointestinal pathogens were detected, in accordance with the type of horse housing. Grey bars: proportions of horses in which pathogens were detected; green bars: proportions of horses in which pathogens were not detected.</p>
Full article ">Figure 3
<p>Seasonal change in the detection rate of zoonotic gastrointestinal pathogens in faecal samples from horses (<span class="html-italic">n</span> = 224) in Greece. The dashed line is the trendline.</p>
Full article ">Figure 4
<p>Box and whisker plot of the age of horses (<span class="html-italic">n</span> = 224) in Greece, in accordance with the detection of zoonotic gastrointestinal pathogens in faecal samples and the presence of livestock at the same premises. Green bars: horses in which pathogens were not detected; grey bars: horses in which pathogens were detected; motif pattern: no presence of livestock at same premises; full pattern: presence of livestock at same premises.</p>
Full article ">Figure 5
<p>Biplot of results of principal component analysis for detection of zoonotic gastrointestinal pathogens in faecal samples from horses in Greece, in accordance with season when sampling took place, location of horse (part of the country), age of horse, and presence of livestock at the same premises. Grey dots: horses in which pathogens were detected; green dots: horses in which pathogens were not detected.</p>
Full article ">Figure 6
<p>Seasonal change in the detection rate of two zoonotic gastrointestinal pathogens concurrently in faecal samples from horses (<span class="html-italic">n</span> = 224) in Greece. The dashed line is the trendline.</p>
Full article ">
17 pages, 9828 KiB  
Review
Congenital Diarrhoeas and Enteropathies
by Jutta Köglmeier and Keith James Lindley
Nutrients 2024, 16(17), 2971; https://doi.org/10.3390/nu16172971 - 3 Sep 2024
Viewed by 576
Abstract
Congenital diarrhoeas and enteropathies (CODE) are a heterogeneous group of disorders. Many affected infants present with catastrophic dehydration in the first few days of life, although the clinical phenotype is variable. Advances in the understanding of underlying pathomechanisms and genetic testing, as well [...] Read more.
Congenital diarrhoeas and enteropathies (CODE) are a heterogeneous group of disorders. Many affected infants present with catastrophic dehydration in the first few days of life, although the clinical phenotype is variable. Advances in the understanding of underlying pathomechanisms and genetic testing, as well as improved management, in particular intravenous nutrition support, have allowed affected patients to survive well beyond childhood. Awareness and understanding of these rare diseases are hence needed, both amongst paediatricians and adult physicians. In this review, we discuss the different groups of disorders based on a review of the current literature and provide a diagnostic and therapeutic approach. Many of the subtypes of CODE result in the need for prolonged or indefinite parenteral nutrition. Further research is needed to identify new CODE to improve the recognition and management of these children, which can assist in developing new targeted therapies and potentially a long-term cure. Full article
Show Figures

Figure 1

Figure 1
<p>Classification of CODE according to underlying defect. Genetic defects are in green, and clinical phenotypes are in red. CTE—congenital tufting enteropathy; MVID—microvillus inclusion disease; THE—tricho-hepato-enteric syndrome; MPI-GDG—congenital disorder of glycosylation type 1b; PLE—syndromic protein-losing enteropathies; ISH—infantile systemic hyalinosis; HLLS—Hennekam lymphangiectasia lymphoedema syndrome.</p>
Full article ">Figure 2
<p>Schematic representation of small bowel enterocytes depicting some of the apical and basolateral ion channels/pumps/enzymes. SLC26A3—chloride/bicarbonate antiporter; SLC9A3—sodium/hydrogen antiporter; SLC5A1—sodium/glucose cotransporter; CFTR—cystic fibrosis transmembrane receptor (see text for further details).</p>
Full article ">Scheme 1
<p>Capsule endoscopy image showing extensive intestinal lymphangiectasia (with permission).</p>
Full article ">Scheme 2
<p>MRI chest showing right basal cystic lesion extending into medial left lung (with permission).</p>
Full article ">
16 pages, 2276 KiB  
Article
Passive Immunotherapy of Cynomolgus Monkeys with Anti-Rotavirus IgY
by Gentil Arthur Bentes, Juliana Rodrigues Guimarães, Eduardo de Mello Volotão, Natália Maria Lanzarini, Alexandre dos Santos da Silva, Noemi Rovaris Gardinali, Renato Sergio Marchevsky, José Paulo Gagliardi Leite, Jaqueline Mendes de Oliveira and Marcelo Alves Pinto
Pharmaceutics 2024, 16(9), 1149; https://doi.org/10.3390/pharmaceutics16091149 - 30 Aug 2024
Viewed by 635
Abstract
Immunoglobulins Y (IgY) purified from egg yolks of hens represents an attractive, cost-effective alternative for the development of new diagnostic and therapeutic platforms. In this study, we evaluated the therapeutic efficacy of rotavirus-specific IgY in a cynomolgus monkey (Macaca fascicularis) model. [...] Read more.
Immunoglobulins Y (IgY) purified from egg yolks of hens represents an attractive, cost-effective alternative for the development of new diagnostic and therapeutic platforms. In this study, we evaluated the therapeutic efficacy of rotavirus-specific IgY in a cynomolgus monkey (Macaca fascicularis) model. Animals were experimentally infected with human rotavirus Group A (RVA), the most common cause of severe acute diarrhoea among young children worldwide. Animals were administered human RVA (3.1 × 107 FFU/mL) by oral gavage, challenged with 2.5 mg of anti-RVA IgY orally, and monitored for five days according to clinical, haematological and biochemical parameters; serum electrolyte levels; viral shedding; and histopathological changes. Immunotherapy with anti-RVA IgY had a protective effect against severe rotavirus-induced enteritis in four of the ten treated monkeys, as evidenced by histopathological findings. Although only one animal had diarrhoea, all but one exhibited virus shedding regardless of the treatment. Full article
Show Figures

Figure 1

Figure 1
<p>Histological analysis of the jejunum, ileum, and colon of the negative control (NC) (<b>A</b>–<b>C</b>), positive control (PC) (<b>D</b>–<b>F</b>), proof of concept (PoC) (<b>G</b>–<b>I</b>), orally treated (OT) (<b>J</b>–<b>L</b>), and orally and intravenously treated (OIVT) (<b>M</b>–<b>O</b>) cynomolgus monkeys. Images (×100 magnification) of the following H&amp;E-stained tissue sections: jejunum: (<b>A</b>) normal villi height (NC); (<b>D</b>) decreased villi height, hyperplastic crypts and oedema in the lamina propria with desquamation (arrow) and loss of enterocytes (PC); (<b>G</b>) villous shortening, epithelial vacuolation, desquamation, and loss of enterocytes (arrow) (PoC); (<b>J</b>) reduction in the villus-to-crypt length ratio, villus loss and fusion at the tips of villi (arrow) (OT); (<b>M</b>) reduction in the villus-to-crypt length ratio, villus loss and fusion (OIVT). Ileum: (<b>B</b>) normal villus height (NC); (<b>E</b>) irregular villous architecture and height, with crypt hyperplasia (arrow) (PC); (<b>H</b>) highly vacuolated villus, with oedema and coagulation necrosis in the middle and upper regions of villi (arrow) (PoC); (<b>K</b>) severe villus atrophy and fusion, with cellular debris in the lamina propria (arrow head), and nodular lymphoid hyperplasia (arrow) limited to the lamina propria (OT); (<b>N</b>) loss of villous enterocytes with necrosis and sloughing of the degenerate epithelial barrier (OIVT). Colon: (<b>C</b>) normal mucosa with a relatively high goblet-to-absorptive cell ratio (NC); (<b>F</b>) denudation of the epithelial mucosa, massive lymphoid aggregation (arrow), and dense infiltration of the lamina propria with mononuclear cells (arrow head) (PC); (<b>I</b>) sloughing of epithelial cell surfaces and moderate oedema of the lamina propria (arrow head), with lymphoid nodules (arrow) (PoC); (<b>L</b>) thinning of the colon mucosa with epithelial desquamation (arrow) (OT); (<b>O</b>) desquamated and necrotic epithelium (arrow head) and focal sloughing of sheets of epithelium, with oedema of the lamina propria (arrow) (OIVT).</p>
Full article ">Figure 2
<p>Indirect immunofluorescence images of jejunum sections from RVA-inoculated cynomolgus monkeys. (<b>A</b>) Negative control: absence of fluorescence; (<b>B</b>) positive control, AE11: NSP4+ epithelial cells (enterocytes); (<b>C</b>) proof of concept, animal R9: NSP4+ cells in the inflammatory infiltrate of the interstitial space of Lieberkühn crypts; (<b>D</b>) proof of concept, animal Q5: NSP4+ cells in enterocytes; (<b>E</b>) orally treated AE17 monkey: NSP4+ cells in epithelial cells from the Lieberkühn crypt; (<b>F</b>) orally treated AE5 monkey: NSP4+ cells in lamina propria from the crypt area; (<b>G</b>) orally and intravenously treated AD13 monkey: NSP4+ cells in the interstitial space of the crypt zone; (<b>H</b>) orally and intravenously treated AE13 monkey: NSP4+ infiltrating cells in the interstitial space of the crypt zone. NSP4 staining inside enterocytes from the crypt region. Anti-NSP4 antibody (Alexa Fluor<sup>®</sup> 488–green) was used; nuclei were stained with DAPI (blue), and parenchyma was stained with Evans blue (red).</p>
Full article ">Figure 3
<p>Indirect immunofluorescence (IIF) images of IFN-γ, CD29<sup>+</sup>, CD3<sup>+</sup>CD4<sup>+</sup> and CD3<sup>+</sup>CD8<sup>+</sup> T lymphocytes in jejunum sections from the negative control, positive control, and orally treated RVA-inoculated cynomolgus monkeys. Negative control: shaded area (<b>A</b>); orally treated, animal AE5: IFN-gamma-positive cells (<b>B</b>); CD29<sup>+</sup> T cells in jejunum tissue section (<b>C</b>); orally treated, animal AE17: anti-CD4/Alexa Fluor<sup>®</sup> 647 antibody (red), anti-CD4/FITC (green), and DAPI-stained nuclei (blue), (×400) (<b>D</b>); anti-CD8/Alexa Fluor<sup>®</sup> 647 antibody (red), anti-CD4/FITC (green) and DAPI-stained nuclei (blue) (<b>E</b>); and CD29<sup>+</sup> T cells in jejunum tissue section (<b>F</b>).</p>
Full article ">
13 pages, 356 KiB  
Article
Diarrhoeagenic Escherichia coli and Salmonella spp. Contamination of Food and Water Consumed by Children with Diarrhoea in Maputo, Mozambique
by Sara Faife, Custódia Macuamule, Josphat Gichure, Tine Hald and Elna Buys
Int. J. Environ. Res. Public Health 2024, 21(9), 1122; https://doi.org/10.3390/ijerph21091122 - 26 Aug 2024
Viewed by 701
Abstract
In Mozambique, about 500,000 cases of diarrhoea were caused by foodborne pathogens in 2018. A review of the epidemiology of diarrhoea in children under five showed a high disease burden. This study aimed to identify Diarrhoeagenic Escherichia coli (DEC) and Salmonella spp. contamination [...] Read more.
In Mozambique, about 500,000 cases of diarrhoea were caused by foodborne pathogens in 2018. A review of the epidemiology of diarrhoea in children under five showed a high disease burden. This study aimed to identify Diarrhoeagenic Escherichia coli (DEC) and Salmonella spp. contamination of food and water in urban and rural areas of Maputo consumed by children under five with diarrhoea. One hundred and eighty-six children with diarrhoea were selected from Primeiro de Maio and Marracuene Health Care Centres from the Kamaxakeni and Marracuene districts, respectively. Food (n = 167) and water (n = 100) samples were collected in children’s households for diarrhoeagenic bacterial identification. Interviews were conducted using a semi-structured questionnaire to collect data about demographics and foods consumed a week before the children’s diarrhoea episodes. The prevalence of both DEC and Salmonella spp. was 9.8% in food and 5.4% in water samples. DEC was most prevalent in cereals (urban = 2.8%; rural = 2.4%) and water samples (urban = 1.4%; rural = 3.3%). Salmonella spp. was mainly detected in cereals (urban = 0.7%; rural = 0.8%). Diarrhoeagenic pathogens were associated with the type of food frequently consumed by children under five years with diarrhoea (infant formula, fruit puree, ready-to-eat meals, and bottled water), while the association with demographics was absent. We found that the infant foods consumed by children with diarrhoea are associated with DEC and Salmonella spp., and the prevalence of these contaminants is higher in the rural (8.9%) than in the urban area (6.3%), showing the need for caregiver education on food handling practices. Full article
8 pages, 464 KiB  
Article
The Incidence of Clostridioides difficile Infection in the Post-COVID-19 Era in a Hospital in Northern Greece
by Maria Terzaki, Dimitrios Kouroupis, Charalampos Zarras, Dimitrios Molyvas, Chrysi Michailidou, Panagiotis Pateinakis, Konstantina Mpani, Prodromos Soukiouroglou, Eleftheria Paida, Elisavet Simoulidou, Sofia Chatzimichailidou, Konstantinos Petidis and Athina Pyrpasopoulou
Diseases 2024, 12(8), 190; https://doi.org/10.3390/diseases12080190 - 20 Aug 2024
Viewed by 812
Abstract
Clostridioides difficile infection (CDI) has evolved to be the most significant cause of healthcare-associated diarrhoea and one of the leading representatives of healthcare-associated infections, with a high associated mortality. The aim of this retrospective study was to record the incidence rates and the [...] Read more.
Clostridioides difficile infection (CDI) has evolved to be the most significant cause of healthcare-associated diarrhoea and one of the leading representatives of healthcare-associated infections, with a high associated mortality. The aim of this retrospective study was to record the incidence rates and the epidemiological and clinical features of CDI in a large tertiary hospital of northern Greece in the years 2022-2023. All patients with CDI-compatible symptomatology and a positive CDI diagnostic test (GDH—glutamate dehydrogenase and toxin-positive FIA—Fluorescent Immuno-chromatography—SD Biosensor, and/or film array) were included (104 from a total of 4560 admitted patients). Their demographic, laboratory, and clinical data were recorded and analysed. The incidence of CDI in admitted patients was found to be higher than previous reports in the geographical area, reaching 54.6/10,000 patient days and following a rising trend over the course of the study. Thirty-day mortality was high (39.4%), potentially related to new emerging hypervirulent C. difficile strains. In view of the high prevalence of multidrug-resistant organisms in the region, and the significant mortality associated with this infection, these findings particularly point to the need for the implementation of organized surveillance and infection prevention protocols. Full article
(This article belongs to the Special Issue Infectious Disease Epidemiology 2024)
Show Figures

Figure 1

Figure 1
<p>Up to 31 December 2023, incidence of CDI among inpatients of medical wards of Hippokration Hospital. (<b>a</b>) Total cases of community-acquired (CA) CDI and healthcare-associated (HA) CDI per semester. (<b>b</b>) CDI incidence in cases/10,000 patient days.</p>
Full article ">
12 pages, 1354 KiB  
Article
Moving beyond Symptom Criteria to Diagnose and Treat Functional Disorders: Patient-Reported Symptoms of Functional Lower Gastrointestinal Disorders Correlate Poorly with Objective Assessment of Luminal Contents Seen on Intestinal Ultrasound
by Claudia Brick, Heidi Su, Kirstin Taylor and Rebecca Burgell
J. Clin. Med. 2024, 13(16), 4759; https://doi.org/10.3390/jcm13164759 - 13 Aug 2024
Viewed by 638
Abstract
Background/Objectives: The diagnosis of lower functional gastrointestinal disorders (FGIDs) is currently based on subjective and unreliable patient-reported symptoms, with significant clinical overlap between diagnosed phenotypes. Objective biomarkers are urgently sought. Gastrointestinal ultrasound (GIUS) can objectively and non-invasively assess luminal contents. This study aimed [...] Read more.
Background/Objectives: The diagnosis of lower functional gastrointestinal disorders (FGIDs) is currently based on subjective and unreliable patient-reported symptoms, with significant clinical overlap between diagnosed phenotypes. Objective biomarkers are urgently sought. Gastrointestinal ultrasound (GIUS) can objectively and non-invasively assess luminal contents. This study aimed to assess the utility of GIUS in phenotyping patients with lower FGIDs. Methods: Patients with lower FGIDs underwent a GIUS and completed the Rome IV Diagnostic Questionnaire, SAGIS questionnaire, and 100 mm VAS score for overall symptom severity. The faecal loading score (FLS) was obtained using a modified Leech score, where an FLS of >37 was consistent with clinically significant constipation. Results: Eighty-eight patients fulfilled the study requirements. In total, 56 met the Rome IV criteria for irritable bowel syndrome (IBS) subtypes, while 23 met the criteria for functional constipation (FC), 4 for functional diarrhoea (FD), and 5 for other diagnoses. Patients reporting constipation-predominant symptoms had a significantly higher median FLS than those describing diarrhoea-predominant symptoms (FLS = 40 [IQR 20.0–53.3] vs. 13.3 [IQR 6.7–40.0], respectively). However, 27% of patients describing diarrhoea had significant faecal loading on GIUS, and of those who described constipation, 34% did not have significant faecal loading. Sensitivity and specificity for the detection of FLS-indicated constipation by the Rome IV criteria were low at 59% and 66%, respectively. Conclusions: The symptom-based diagnosis of FGID subtypes based on the Rome IV criteria is a poor predictor of faecal loading. These findings should prompt further exploration of the limitations of symptom-based assessment and a shift towards physiological assessment of patients with FGIDs such as gastrointestinal ultrasound to develop more targeted therapy. Future research is underway to determine if targeting objective physiological endpoints results in improved clinical outcomes. Full article
(This article belongs to the Special Issue Gastrointestinal Motility Disorders)
Show Figures

Figure 1

Figure 1
<p>Sonographic images of faecal loading with corresponding scoring criteria: (<b>A</b>) empty colon (score = 0)—no stool within lumen, colon collapsed; (<b>B</b>) mild loading (score = 1)—some stool within lumen but colon remains relatively collapsed; (<b>C</b>) moderate loading (score = 2)—stool within lumen, colon full, rounded appearance, and unable to see the posterior wall; (<b>D</b>) severe loading (score = 3)—stool with lumen, colon distended, unable to see the posterior wall, and other features such as crescent-shaped acoustic shadows with haustrations.</p>
Full article ">Figure 2
<p>Distribution of intestinal ultrasound faecal loading scores (IUS FLSs) stratified by lower functional gastrointestinal disorder as defined by the Rome IV criteria (functional constipation; irritable bowel syndrome with predominant constipation; IBS-mixed; IBS indeterminant; IBS with diarrhoea; functional diarrhoea). Five patients categorised as “Other” are removed; <span class="html-italic">n</span> = 83.</p>
Full article ">Figure 3
<p>Distribution of intestinal ultrasound faecal loading scores (FLSs) stratified by predominant symptom category. Five patients categorised as “Other” are removed; <span class="html-italic">n</span> = 83.</p>
Full article ">
18 pages, 13305 KiB  
Article
The Preventive Effect of Low-Molecular Weight Oyster Peptides on Lipopolysaccharide-Induced Acute Colitis in Mice by Modulating Intestinal Microbiota Communities
by Qihang Wu, Haisheng Lin, Weiqiang Shen, Wenhong Cao, Xiaoming Qin, Jialong Gao, Zhongqin Chen, Huina Zheng, Saiyi Zhong and Haoyang Huang
Foods 2024, 13(15), 2391; https://doi.org/10.3390/foods13152391 - 29 Jul 2024
Viewed by 886
Abstract
Colitis causes inflammation, diarrhoea, fever, and other serious illnesses, posing a serious threat to human health and safety. Current medications for the treatment of colitis have serious side effects. Therefore, the new strategy of creating a defence barrier for immune function by adding [...] Read more.
Colitis causes inflammation, diarrhoea, fever, and other serious illnesses, posing a serious threat to human health and safety. Current medications for the treatment of colitis have serious side effects. Therefore, the new strategy of creating a defence barrier for immune function by adding anti-inflammatory foods to the daily diet is worth advocating for. Low-molecular weight oyster peptides (LOPs) are a natural food with anti-inflammatory activity extracted from oysters, so intervention with LOPs is likely to be an effective preventive solution. The aim of this study was to investigate the preventive effect of LOPs on lipopolysaccharide (LPS)-induced acute colitis inflammation in mice and its underlying mechanism. The results showed that LOPs not only inhibited the colonic histopathy in mice induced by LPS-induced inflammation but also reduced the inflammatory response in the blood. In addition, LOPs significantly increased the number of beneficial bacteria (Alistipes, Mucispirillum, and Oscillospira), decreased the number of harmful bacteria (Coprobacillus, Acinetobater) in the intestinal microbiota, and further affected the absorption and utilisation of short-chain fatty acids (SCFAs) in the intestinal tract. In conclusion, dietary supplementation with LOPs is a promising health-promoting dietary supplement and nutraceutical for the prevention of acute colitis by reducing the inflammatory response and modulating the intestinal microbial communities. Full article
(This article belongs to the Section Foods of Marine Origin)
Show Figures

Figure 1

Figure 1
<p>Animal experimental design.</p>
Full article ">Figure 2
<p>Peptide sequence of the LOPs: (<b>A</b>) peptide molecular weight distribution of LOP; (<b>B</b>) count of peptides of different lengths in the LOPs.</p>
Full article ">Figure 3
<p>Experimental design and physiological characteristics of mice before and after intraperitoneal injection. (<b>A</b>) Changes in the body weight of mice in each group before intraperitoneal injection of LPS; (<b>B</b>) differences in faeces and behaviour between the BC and LPS groups of mice; (<b>C</b>) Diarrhea score; (<b>D</b>) weight loss. ** <span class="html-italic">p</span> &lt; 0.01, *** <span class="html-italic">p</span> &lt; 0.001 vs. the BC group; <sup>#</sup> <span class="html-italic">p</span> &lt; 0.05, <sup>##</sup> <span class="html-italic">p</span> &lt; 0.01, <sup>###</sup> <span class="html-italic">p</span> &lt; 0.001 vs. the LPS group.</p>
Full article ">Figure 4
<p>Colon condition (<b>A</b>–<b>C</b>). * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, vs. the BC group; <sup>#</sup> <span class="html-italic">p</span> &lt; 0.05, <sup>##</sup> <span class="html-italic">p</span> &lt; 0.01, vs. the LPS group.</p>
Full article ">Figure 5
<p>Blood routine (<b>A</b>–<b>C</b>). * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, *** <span class="html-italic">p</span> &lt; 0.001 vs. the BC group; <sup>#</sup> <span class="html-italic">p</span> &lt; 0.05, <sup>##</sup> <span class="html-italic">p</span> &lt; 0.01,<sup>###</sup> <span class="html-italic">p</span> &lt; 0.001 vs. the LPS group.</p>
Full article ">Figure 6
<p>The concentration of the serum pro-inflammatory factors. (<b>A</b>) Concentration of TNF-α; (<b>B</b>) concentration of IL-1β; (<b>C</b>) concentration of IL-6; (<b>D</b>) concentration of NO. ** <span class="html-italic">p</span> &lt; 0.01, *** <span class="html-italic">p</span> &lt; 0.001 vs. the BC group; <sup>#</sup> <span class="html-italic">p</span> &lt; 0.05, <sup>##</sup> <span class="html-italic">p</span> &lt; 0.01, <sup>###</sup> <span class="html-italic">p</span> &lt; 0.001 vs. the LPS group.</p>
Full article ">Figure 7
<p>Representative histological images. (<b>A</b>) Mice colon tissue magnified by 100×; (<b>B</b>) mice colon tissue magnified by 200×.</p>
Full article ">Figure 8
<p>Concentrations of anti-oxidant indicators in mice colons. (<b>A</b>) T-SOD; (<b>B</b>) CAT; (<b>C</b>) GSH-Px; (<b>D</b>) MDA. * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, *** <span class="html-italic">p</span> &lt; 0.001 vs. the BC group; <sup>#</sup> <span class="html-italic">p</span> &lt; 0.05, <sup>##</sup> <span class="html-italic">p</span> &lt; 0.01,<sup>###</sup> <span class="html-italic">p</span> &lt; 0.001 vs. the LPS group.</p>
Full article ">Figure 9
<p>Diversity analysis. (<b>A</b>) Good’s coverge; (<b>B</b>) α diversity analysis. * <span class="html-italic">p</span> &lt; 0.05, vs. the BC group; <sup>#</sup> <span class="html-italic">p</span> &lt; 0.05, <sup>##</sup> <span class="html-italic">p</span> &lt; 0.01, vs. the LPS group.</p>
Full article ">Figure 10
<p>Structures of the intestinal microbial community in mice. (<b>A</b>) Intestinal microbial analysis of mice at the phylum level. (<b>B</b>) Intestinal microbial analysis of mice at the family level. (<b>C</b>) Cluster heat map of species abundance at the genus level.</p>
Full article ">Figure 11
<p>Concentration of the SCFAs in the colon content of mice (<span class="html-italic">n</span> = 6). * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, *** <span class="html-italic">p</span> &lt; 0.001 vs. the BC group; <sup>#</sup> <span class="html-italic">p</span> &lt; 0.05, <sup>##</sup> <span class="html-italic">p</span> &lt; 0.01, <sup>###</sup> <span class="html-italic">p</span> &lt; 0.001 vs. the LPS group.</p>
Full article ">
Back to TopTop